A carregar...
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
Liver cancers, majority of which are primary hepatocellular carcinoma (HCC), continue to be on the rise in the world. Furthermore, due to the lack of effective treatments, liver cancer ranks the 4(th) most common cause of male cancer deaths. Novel therapies are urgently needed. Over last few years,...
Na minha lista:
| Publicado no: | J Genet Genomics |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7093251/ https://ncbi.nlm.nih.gov/pubmed/32089500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgg.2020.01.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|